Providence St. Vincent Medical Center was designated as a Magnet organization in 2000, 2004, 2009, and 2014 by the ANCC Magnet Recognition Program®. This prestigious designation recognizes excellence in nursing services. In July 2018, Providence St. Vincent Medical Center is applying for re-designation.
Providence’s commitment to patient safety is a high priority among caregivers and that has been recognized by the Oregon Patient Safety Commission. All eight Providence hospitals in Oregon and Providence’s Center for Medically Fragile Children, a residential care facility for young people, were recognized by the commission for meeting an assortment of patient safety targets.
More than 150 people took part as Providence Cancer Center participated in Vice President Biden’s Cancer Moonshot Summit. The goal is to make a decade worth of advances toward a cure in five years, from increasing access to treatment and improving care to freeing trapped data and unleashing new breakthroughs.
Providence Cancer Center is one of 30 centers in the U.S. – and the only center in Oregon – to earn a special designation from the National Pancreas Foundation (NPF). Among other centers are Mayo Clinic, Virginia Mason Medical Center and Johns Hopkins Medical Institutions.
They know every second counts. And when it comes to stroke, the neurointerventional team at Providence St. Vincent Medical Center offers some of the best care in the nation. For the past two months, the stroke team led by Vivek Deshmukh, M.D., neurosurgeon and neurointerventionalist, achieved the fastest average blood clot removal time in the country.
Four Providence hospitals in the Portland have each been designated as a “Diagnostic Imaging Center of Excellence” by The American College of Radiology, or ACR. The four Providence hospitals – Providence Portland Medical Center, Providence St. Vincent Medical Center, Providence Willamette Falls Medical Center and Providence Milwaukie Hospital – are among eight on the West Coast and only 104 in the world to achieve this honor.
A breakthrough drug for treating the most common type of lung cancer was just approved by the Food and Drug Administration ahead of schedule following two successful clinical trials, including one that involved patients at Providence Cancer Center in Portland.
On Halloween, breast cancer patient Melissa Roy-Hart, aka Wonder Woman, allowed reporters to follow her to her final breast cancer treatment at Providence Cancer Center Oncology and Hematology Care Clinic – Southeast.